NORTH TIDE CAPITAL, LLC
Follow13F filer, CIK 1557543, BOSTON, MA
NORTH TIDE CAPITAL, LLC reported $449,407,000 across 12 holdings for the quarter ended 2017-06-30, in a 13F-HR filed 2017-08-14. Its ten largest share positions make up 96.83% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001140361-17-031616
- Period
- 2017-06-30
- Reported value
- $449M
- Holdings
- 12
- Top 10 weight
- 96.83%
- New
- 1
- Sold out
- 5
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| MCKnew | +150,000 | $24.7M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| IMPAX LABORATORIES INCreduced | -2,000,000 | -$32.2M |
| SYNERON MEDICAL LTDexited | -3,000,000 | -$31.6M |
| PRGOreduced | -300,000 | -$22.7M |
| THCreduced | -1,000,000 | -$19.3M |
| ENDO INTL PLCreduced | -1,500,000 | -$16.8M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2017
Share positions as resolved from 13F-HR 0001140361-17-031616, largest first. % of portfolio is the value over $449,407,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| TIVITY HEALTH INCTIVITY HEALTH INC | 2,500,000 | $99.6M | 22.17% | 0 | |||
| SEMSELECT MED HLDGS CORP | 5,000,000 | $76.8M | 17.08% | -700,000 | Timeline | ||
| GILDGILEAD SCIENCES INC | 1,000,000 | $70.8M | 15.75% | 0 | Timeline | ||
| MYLAN NVMYLAN NV | 1,000,000 | $38.8M | 8.64% | 0 | |||
| ENDO INTL PLCENDO INTL PLC | 3,000,000 | $33.5M | 7.46% | -1,500,000 | |||
| SUPERVALU INCSUPERVALU INC | 10,000,000 | $32.9M | 7.32% | 0 | |||
| MCKMCKESSON CORP | 150,000 | $24.7M | 5.49% | new | Timeline | ||
| PRGOPERRIGO CO PLC | 300,000 | $22.7M | 5.04% | -300,000 | Timeline | ||
| THCTENET HEALTHCARE CORP | 1,000,000 | $19.3M | 4.3% | -1,000,000 | Timeline | ||
| IMPAX LABORATORIES INCIMPAX LABORATORIES INC | 1,000,000 | $16.1M | 3.58% | -2,000,000 | |||
| BIOSCRIP INCBIOSCRIP INC | 3,000,000 | $8.14M | 1.81% | 0 | |||
| VIVUS INCVIVUS INC | 5,000,000 | $6.1M | 1.36% | -4,009,300 |
Sold out in Q2 2017
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| XLVSELECT SECTOR SPDR TR | 1,700,000 | $126M | put |
| SYNERON MEDICAL LTDSYNERON MEDICAL LTD | 3,000,000 | $31.6M | shares |
| HORIZON PHARMA PLCHORIZON PHARMA PLC | 692,700 | $10.2M | shares |
| QUORUM HEALTH CORPQUORUM HEALTH CORP | 1,590,200 | $8.65M | shares |
| ARAYACCURAY INC DEL | 154,500 | $734K | shares |
How Q2 2017 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001140361-17-031616 | base | 2017-08-14 | acceptance time not in the bulk data set |